Medscape Medical NewsAll articles

IB NEURO, VERSION 1.0

IMAGING BIOMETRICS, LLC • Radiology • 05/15/2008

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

IB NeuroTM vl.0 is an OsiriX plugin software designed to post-process and analyze dynamically acquired MR datasets by employing established algorithms to generate quantitative perfusion maps for clinical use. The device enhances existing imaging workflows by providing critical parameters such as rCBV, CBF, MTT, and TTP, derived from image intensity variations over time, to assist physicians in clinical assessments.

Summary

IB NeuroTM vl.0 is an OsiriX Plugin software designed for the advanced analysis of dynamically acquired Magnetic Resonance (MR) datasets. Its core function is to generate various parametric perfusion maps, including Relative Cerebral Blood Volume (rCBV), Cerebral Blood Flow (CBF), Mean Transit Time (MTT), and Time to Peak (TTP), utilizing well-established algorithms. Key features of the software include automated correction for contrast agent leakage in rCBV maps, automated brain mask generation, normalization of parameters to normal appearing white matter (NAWM), automated report generation, per-voxel dynamic signal time course viewing, interactive Arterial Input Function (AIF) selection, and automatic export of perfusion maps as DICOM images to enhance existing medical image visualization applications. The intended use of IB NeuroTM is to facilitate the post-processing and display of these dynamic MR datasets, enabling the evaluation of image intensity variations over time for clinical applications. The software accepts data from existing MRI systems, performs quality control checks, and subsequently sends the generated parametric maps to Picture Archiving and Communication Systems (PACS) for viewing and interpretation by trained physicians. This process aims to provide information useful in clinical decision-making by leveraging platform-independent integration into existing server and workstation applications, thereby extending the productivity of current viewers, CAD workstations, and PACS.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

IB NeuroTMOsiriX PluginPerfusion MapsrCBVCBFMTTDynamic MRIAutomated CorrectionDICOMPACS

Device Metadata

Submission Number
K080762
Company
IMAGING BIOMETRICS, LLC
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. What specific algorithms are employed for the automated correction of contrast agent leakage in rCBV maps, and what is their performance validation against manual or alternative established methods?; How robust is the automated brain mask generation across diverse patient anatomies, varying image qualities, and in the presence of significant neurological pathologies that might distort typical brain structures?; What is the clinical evidence or validation supporting the diagnostic or prognostic utility of perfusion parameters when normalized to normal appearing white matter (NAWM) using this specific software, particularly for different neurological conditions?; How does IB NeuroTM vl.0 account for potential variabilities in MR acquisition protocols, such as different contrast agent types, injection rates, or sequence parameters, when calculating the perfusion parameters like CBF and MTT?; Beyond generating parametric maps, are there any built-in quantitative thresholds or decision support features suggested or validated for this software to aid physicians in the interpretation of perfusion data for specific clinical scenarios, such as tumor grading or stroke assessment?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score10/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(server, platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
IB NEURO, VERSION 1.0 - IMAGING BIOMETRICS, LLC | ESL FDA AI Device Intelligence